VITALE, Emanuele
 Distribuzione geografica
Continente #
EU - Europa 108
AS - Asia 32
NA - Nord America 25
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 2
Totale 170
Nazione #
IT - Italia 66
US - Stati Uniti d'America 25
SG - Singapore 11
DE - Germania 10
NL - Olanda 8
TR - Turchia 6
FI - Finlandia 5
GB - Regno Unito 5
ES - Italia 3
FR - Francia 3
HK - Hong Kong 3
NO - Norvegia 3
QA - Qatar 3
XK - ???statistics.table.value.countryCode.XK??? 3
IL - Israele 2
IN - India 2
IR - Iran 2
JP - Giappone 2
PT - Portogallo 2
AT - Austria 1
CI - Costa d'Avorio 1
CN - Cina 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
IE - Irlanda 1
Totale 170
Città #
Palermo 38
Singapore 9
Amsterdam 8
Milan 7
Helsinki 5
Rome 4
Ashburn 3
Chandler 3
Columbus 3
Doha 3
Hong Kong 3
Hoover 3
León 3
Oslo 3
Prizren 3
Trapani 3
Avignon 2
Bielefeld 2
Houston 2
Istanbul 2
Los Angeles 2
Ludwigshafen am Rhein 2
Mumbai 2
Tel Aviv 2
Trofa 2
Whitley Bay 2
Abidjan 1
Ali Mendjeli 1
Bremen 1
Brno 1
Carini 1
Dublin 1
Lille 1
London 1
New Castle 1
Philadelphia 1
Phoenix 1
Pisa 1
Southwark 1
Spring Valley 1
Taranto 1
Teddington 1
Waltham 1
Totale 138
Nome #
Readthrough Inducing Drugs (TRIDs) in human fibroblasts harboring the c.5047 C>T (R1683*) nonsense mutation 75
Unlocking Cellular Secrets: Charting Proteomic Frontiers in LRBA Deficiency Through the Lens of Readthrough Promoters 46
Promoting readthrough of nonsense mutations in CF mouse model: Biodistribution and efficacy of NV848 in rescuing CFTR protein expression 40
Readthrough Approach Using NV Translational Readthrough-Inducing Drugs (TRIDs): A Study of the Possible Off-Target Effects on Natural Termination Codons (NTCs) on TP53 and Housekeeping Gene Expression 24
Totale 185
Categoria #
all - tutte 769
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 769


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202329 0 0 0 16 4 1 0 1 2 1 3 1
2023/202474 2 1 2 4 10 4 2 13 0 3 2 31
2024/202582 8 3 8 11 31 21 0 0 0 0 0 0
Totale 185